social science of hiv and hepatitis c in russia and southeastern europe
DESCRIPTION
Social science of HIV and hepatitis C in Russia and southeastern Europe. Sergii Dvoriak M.D., Ph.D Ukrainian Institute on Public Health Policy, Kyiv, Ukraine. Symposium “Social and Structural Determinants of the HIV Epidemic in Eastern Europe and Central Asia” - PowerPoint PPT PresentationTRANSCRIPT
1
Social science of HIV and hepatitis C in Russia and
southeastern Europe
Sergii Dvoriak M.D., Ph.D
Ukrainian Institute on Public Health Policy,
Kyiv, Ukraine
Symposium “Social and Structural Determinants of the HIV Epidemic in Eastern Europe and Central Asia”IAS 2013 7th IAS Conference on HIV Pathogenesis, treatment and Prevention
30 June – 03 July 2013 – Kuala Lumpur, Malaysia
2
3
4
5
UNAIDS, Global Report, 2011
FACT SHEET Eastern Europe and Central Asia
A steep regional increase in new HIV infections and AIDS-related deaths
In EE&CA, the number of people living with HIV almost tripled between 2000 and 2009. An estimated 1.4 million [1.3 million–1.6 million] people were living with HIV in 2009 compared to 530 000 [470 000–620 000] in 2000.
AIDS-related deaths continue to rise in the region: an estimated 76 000 [60 000–95 000] people died from AIDS-related causes in 2009 compared to 18 000 [14 000–23 000] in 2001, a four-fold increase.
The Russian Federation and Ukraine together account for nearly 90% of newly reported HIV infections.
Ukraine has the highest adult HIV prevalence in all of Europe and Central Asia, at 1.1% [1.0%–1.3%]. Annual HIV diagnoses in Ukraine have more than doubled since 2001.
Between 2000 and 2009, the HIV incidence rate increased by more than 25% in five countries in the region: Armenia, Georgia, Kazakhstan, Kyrgyzstan and Tajikistan.
6
Social Determinants of
HealthComplex and overlapping community, social, economic, and environmental factors that influence an individual’s and a collective community’s risk for health inequities.
7
Structural factors on HIV-Epidemic
Health care andSocial welfare systemsDisease-specific public health responseTreating of vulnerable groups (PWID, Sex
workers, prison populations etc.)Evidence-based drug policy
8
BarriersUnequal distribution of wealth and power;ClassismRacismSexismHomophobiaTransphobiaNarcophobia
9
Poverty
Predisposition to DA Addiction
+ Risky Bhv
Incarceration
HIV, HCV, Mental Health
problems
Unemploymen
t
10
The HIV Epidemic in Ukraine In 1995, the WHO characterized Ukraine as a low
prevalence country. By 1996, all 25 regional capitals in Ukraine reported HIV,
primarily among drug injectors. In some cities, rates of HIV among IDUs rose from nearly
zero in 1994 to more than 50% two years later. Today, Ukraine is the most HIV-affected country in Europe
and Central Asia, with an estimated 260,000 infected between the ages of 15 - 49, or 1.13% of the population in this age range.
Prevalence among PWID – 21.5%. (Bio-behavioral Survey, 2011)
11
Social reasons: The social and economic disintegration that followed the collapse of the Soviet Union in 1991.
With the withdrawal of the Soviet Union in December 1991:
Police controls became ineffective, drugs more readily available, and corruption uncontrolled.
In the first 5 years following the demise of the Soviet Union, the magnitude of the illicit economy was estimated to have tripled, reaching more than 40% of the gross national product from 1994 through 1995.
Locally produced opiates and amphetamines proliferated. Registered drug users increased from 30,000 to 63,000 between 1990 and 1996.
State-supported services, including health care, were reduced or eliminated.
Robert Booth at all. 2013. AIDS Behav
12
Registered drug users in Central Asia (UNODC World Drug Report, 2010)
13
Russia547,000 – registered addicts
102.5 mln of age 15-64 Estimated Prevalence 1.64% Total ~1.68 mln drug users
14
HIV Incidence by Mode of Transmission in Russia, 1987-2008
15
HIV transmission in Ukraine
Injection of drugsFrom mother to childSexual
Undetermined
Data of the Ukrainian AIDS Center
1995 - 1998
79,1%
3,8%2,8% 14,3%
16
Mode of Transmission Attributed to HIV
Cases by Gender in Ukraine, 2005-2011
17
Monitoring of Epidemic Trends
The main indicator– HIV prevalence among high-risk groups
Example – HIV prevalence among IDUs using drugs at least 2 years
2005г. – 23,8%2006г. – 20,2%2007г. – 18,9%
18
HIV prevalence among recent IDUs and IDU coverage by prevention programs, 2004-2011
• HIV Prevalence among recent IDUs (injecting for less than 3 years) was used as proxy incidence.
• Median value for 8 cities: Donetsk, Lutsk, Odessa, Poltava, Simferopol, Summy, Kharkov, Kherson.
• Prevention program coverage at last 12 month
• With increasing coverage over the last 6 years, HIV incidence has been declining significantly: from 29.9% percent in 2004 to 5.5% in 2011
2004
2005
2006
2007
2008
2009
2010
2011
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
0
5000
10000
15000
20000
25000
30000
35000
40000
Распространенность ВИЧ, %HIV prevalence, % Coverage
19
Prevalence of Hepatitis C among People who Inject Drugs*
*Cumulative information on infections over the last decades. Incidence of hepatitis C infections is unavailable in most countries.
20
21
STOP HARM REDUCTION!NEEDLE / SYRINGES EXCHANGE
PROGRAMS STIMULATE A TOLERANCE TOWARD PATIENTS WITH DRUG ABUSE AND VIOLATORS OF RUSSIAN FEDERATION’ LEGISLATION. RUSSIAN MINISTER OF HEALTH (2010)
22
23
• “In honor of Hitler it was named Adolphine and later Dolophine”.• “In the majority of nations methadone was completely prohibited. Any supply of this compound is stored and safely put away completely in the West”. • “Methadone was used as a detonator in conducting so called ‘colored’ revolutions. It was established with the breakup of Yugoslavia: there was a factory made for the production of methadone and it was distributed for free, until civil unrest. Then the factory was closed and thousands of drug users began to vandalize and destroy everything in their way”.
“Rossiyskaya Gazeta”
About methadone
24
Russian Authorities are categorically against OST
“EC countries make a pressure to us for
implementation of OST. They want we do treat drug addicts by other drugs”.
FDCS will not allow to stick Russia methadone therapy.
“The USA and some European countries support us”.
25I se
mester
2008
II sem
ester
2008
I semest
er 200
9
II sem
ester
2009
I semest
er 201
0
II sem
ester
2010
I semest
er 201
1
II sem
ester
2011
I semest
er 201
2
II sem
ester
2012
I semest
er 201
30
1000
2000
3000
4000
5000
6000
7000
8000
52
816 864 831 831 842 814 804 835 831 821827 670
1640 1640
3221
4729
54735828
61596508 6773
Substituton Maintenance Therapy in Ukraine, 2008-2013
Buprenorphine Methadone
26
804 798 795 806 804 817 835 845 839 840 846 830
5828 5852 5883 5977 6054 6084 6159 6249 6263 6283 6344 6431
0
1000
2000
3000
4000
5000
6000
7000
January February March April May June July August September October November December
Number of OST patients in Ukraine, 2012
Buprenorphine Methadone
27
Study of Structural Barriers to HIV Prevention and Treatment Among Drug Injectors in Odessa, Ukraine (2010).
• Legal and economy collapse leaded to increasing risky behavior.
• The epidemic is largely sustained by the lack of government resources devoted to the problem, the continued risky drug using practices of injection and,
perhaps most importantly by the risk environment surrounding drug users.• Collaboration and
especially financial support of government to NGOs is very poor.
28
Opinions of Most Effective Strategies for Treating Addiction
(N=239)
IncarcerationReligion
MedicationFamily supportRehabilitation
EmploymentSubstitution Therapy
DetoxNew environment
Folk Medicine
0.0 2.0 4.0 6.0 8.0 10.0 12.0 14.0 16.0 18.0 20.018.9
17.714.0
11.910.7
8.27.4
4.54.1
0.8
Percent (%) Responding. F.Altice et al. 2013
29
CONCLUSIONSMany social barriers in FSU countries
continue to support the epidemics (HIV & HCV).
Joint efforts needed to change drug policy, drug treatment with HIV.HCV prevention; and eliminate stigma from PWID.
Drug policy and treatment/prevention approaches have to be based on scientific evidence.
Public health issues must be the priority